Biotinylated Sheep Anti-Human Apolipoprotein AII | ABMC-B05
- SKU:
- ABMC-B05
- Availability:
- Usually shipped in 5 working days
Description
Biotinylated Sheep Anti-Human Apolipoprotein AII | ABMC-B05
| Host Species: | Sheep |
| Concentration: | 1 mg/ml (OD 1.35 / 280 nm) |
| Antigen: | Human Apolipoprotein AII |
| Purification: | Affinity purified |
| Form: | Freeze dried powder |
| Buffer: | 75 mM Sodium Phosphate, 75 mM NaCl, 0.5 mM EDTA, 0.02% NaN3, pH 7.2 |
| Specificity | Specifically binds to human apo AII. Dilution for immunoblot and ELISA range: 1,000 to 80,000. |
| Use: | The antibody can be used for detection of apo AII in plasma and lipoproteins, immunoassays, immunoblots, enzyme conjugation, or biotinylation. |
| Storage: | -20°C for long-term storage, 4°C for short- term storage. Aliquot to avoid repeated freezing and thawing. |
| Form: | Freeze dried powder |
| Stabilizer: | 10 mg / ml Bovine Serum Albumin. |
|
Reconstitution and Storage: |
Freeze-dried product should be stored refrigerated until opened. After opening, restore to suggested ml volume with distilled water. If it is not completely clear after standing for 1-2 hours at room temperature, centrifuge the product. It is stable for several weeks at 4°C as an undiluted liquid. Do not use for more than one day after dilution. For extended storage after reconstitution, we suggest aliquot to avoid repeated freezing and thawing; or the addition of an equal volume of glycerol to make a final glycerol concentration of 50%, followed by storage at -20°C. The concentration of protein and buffer salts will decrease to one-half of the original after the addition of glycerol. |
*These products are for research or manufacturing use only, not for use in human therapeutic ordiagnostic applications.
IMPORTANCE
Apo AII comprises 25% of HDL. It exists in human plasma as a dimer of 2 identical chains of 77 amino acid residues, joined by disulfide. The molecular weight is reported to be 8.7 kDa for a single chain (Brewer et al., 1972).
Studies on mouse reported that apo AII may be proatherogenic (Warden et al., 1993); however, case-control study in the large European Prospective Investigation demonstrated that plasma Apo AII concentrations were strongly inversely correlated with CHD events (Birjmohun et al., 2007).
Related Products
Related Products
Biotinylated Goat Anti-Human Apolipoprotein AII | ABMC-B04
Biotinylated Sheep Anti-Human Apolipoprotein (a) | ABMC-B02
Sheep Anti-Human Apolipoprotein AII Affinity Pure | ABMC-A05
FITC-conjugated Sheep Anti-Human Apolipoprotein AII | ABMC-F05
HRP-conjugated Sheep Anti-Human Apolipoprotein AII | ABMC-H05
Sheep Anti-Human Apolipoprotein AII Neat Antiserum | ABMC-S05
Human Apolipoprotein AII (Apo AII) | ABMC-P05
Biotinylated Goat Anti-Human Apolipoprotein CII | ABMC-B08
